Rosenwald Lindsay A MD

SEC CIK: 0000941841

SEC filings (opens in a new tab)

No open-market purchases or sales filed in the past year.

Current role at each company

DERM Journey Medical CorpDirectoras of Jun 26, 2026
FBIO Fortress Biotech, Inc.PRESIDENT, CEO & CHAIRMANas of Mar 20, 2026
CKPT Checkpoint Therapeutics, Inc.Directoras of May 30, 2025
ATXI Avenue Therapeutics, Inc.Directoras of Sep 25, 2024
MBIO Mustang Bio, Inc.Directoras of Jul 7, 2023

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: –; 0 filings
Net: –; Bought minus sold
Companies: 0; With open-market trades

Trades

Every Form 4 that lists Rosenwald Lindsay A MD as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

FBIO Fortress Biotech, Inc.

PRESIDENT, CEO & CHAIRMAN16 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Sep 25, 2024 (view filing)4:45 PM ET	Sep 23	2 days	Rosenwald Lindsay A MDPRESIDENT, CEO & CHAIRMAN	PPurchaseCommon stock, par value $0.001	+763.4K	$1.84	+$1.40M	+26.4%3.66M after
Sep 25, 2024 (view filing)4:45 PM ET	Sep 23	2 days	Rosenwald Lindsay A MDPRESIDENT, CEO & CHAIRMAN	PPurchase	+763.4K	$0.125	+$95.4K	–763.4K after	Derivative
Jul 15, 2024 (view filing)	Jul 11	4 days	Rosenwald Lindsay A MDPresident, CEO & Chairman	PPurchaseSERIES A CUMULATIVE PERPETUAL PREFERRED STOCK	+5.00K	$7.48	+$37.4K	+4.1%127.5K after
Jul 11, 2024 (view filing)	Jul 9	2 days	Rosenwald Lindsay A MDPresident, CEO & Chairman	PPurchaseSERIES A CUMULATIVE PERPETUAL PREFERRED STOCK	+5.00K	$7.39	+$37.0K	+4.3%122.5K after
Jul 10, 2024 (view filing)	Jul 8	2 days	Rosenwald Lindsay A MDPresident, CEO & Chairman	PPurchaseSERIES A CUMULATIVE PERPETUAL PREFERRED STOCK	+5.00K	$7.35	+$36.8K	+4.4%117.5K after
Jul 1, 2024 (view filing)	Jun 28	3 days	Rosenwald Lindsay A MDPresident, CEO & Chairman	PPurchaseCOMMON STOCK, PAR VALUE $0.001	+20.0K	$1.64	+$32.8K	+0.7%2.89M after
May 20, 2024 (view filing)	May 16	4 days	Rosenwald Lindsay A MDPresident, CEO & Chairman	PPurchaseCOMMON STOCK, PAR VALUE $0.001	+10.0K	$1.76	+$17.6K	+0.3%2.87M after
Jan 9, 2024 (view filing)	Jan 5	4 days	Rosenwald Lindsay A MDPresident, CEO & Chairman	PPurchaseCOMMON STOCK, PAR VALUE $0.001	+50.0K	$2.38	+$119.0K	+1.8%2.86M after
Nov 16, 2023 (view filing)	Nov 14	2 days	Rosenwald Lindsay A MDPresident, CEO & Chairman	PPurchaseCOMMON STOCK, PAR VALUE $0.001	+1.57M	$1.70	+$2.66M	+152.2%2.60M after
Nov 16, 2023 (view filing)	Nov 14	2 days	Rosenwald Lindsay A MDPresident, CEO & Chairman	PPurchase	+1.57M	$0.00	$0	–1.57M after	Derivative

See all 16 trades at FBIO

DERM Journey Medical Corp

Director3 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change
Mar 27, 2024 (view filing)	Mar 25	2 days	Rosenwald Lindsay A MDDirector	PPurchaseCommon Stock, $0.0001 par value	+10.0K	$3.04	+$30.4K	+7.4%144.2K after
Mar 25, 2024 (view filing)	Mar 22	3 days	Rosenwald Lindsay A MDDirector	PPurchaseCommon Stock, $0.0001 par value	+20.0K	$3.40	+$68.0K	+17.5%134.2K after
Sep 8, 2023 (view filing)	Sep 6	2 days	Rosenwald Lindsay A MDDirector	PPurchaseCommon Stock, par value $0.0001 per share	+100.0K	$2.23	+$223.0K	+702.0%114.2K after

ATXI Avenue Therapeutics, Inc.

Director1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Sep 12, 2023 (view filing)	Sep 8	4 days	Rosenwald Lindsay A MDDirector	PPurchase	+348.7K	$0.72	+$251.0K	+6,178.9%354.3K after

MBIO Mustang Bio, Inc.